Innovent Biologics, Inc.

Innovent Biologics, Inc.verified

1801.HK

Price:

$80.75

Market Cap:

$121.87B

Innovent Biologics, Inc. operates as a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases. Its principal drug candidate is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody for the treatment of cancer, Hodgkin's lymphoma, and esophageal carcinoma. The company also offers Byvasda for the treatment of several malignant tumors; Halpryza for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and Wegener's granulomatosis; Pemazyre for the treatment of adults with locally advanced or metastatic cholangiocarci...[Read more]

Industry

Biotechnology

IPO Date

2018-10-31

Stock Exchange

HKSE

Ticker

1801.HK

The Current Ratio as of June 2025 (TTM) for Innovent Biologics, Inc. (1801.HK) is 2.35

According to Innovent Biologics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.35. This represents a change of -21.56% compared to the average of 3.00 of the last 4 quarters.

Innovent Biologics, Inc. (1801.HK) Historical Current Ratio (quarterly & annually)

How has 1801.HK Current Ratio performed in the past?

The mean historical Current Ratio of Innovent Biologics, Inc. over the last ten years is 7.16. The current 2.35 Current Ratio has changed 3.18% with respect to the historical average. Over the past ten years (40 quarters), 1801.HK's Current Ratio was at its highest in in the December 2017 quarter at 8.85. The Current Ratio was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

7.16

Median

5.23

Minimum

2.35

Maximum

24.55

Innovent Biologics, Inc. (1801.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Innovent Biologics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 21.87%

Maximum Annual Current Ratio = 24.55

Minimum Annual Increase = -63.93%

Minimum Annual Current Ratio = 2.35

Quarterly (TTM)
Annual
YearCurrent RatioChange
20242.35-21.61%
20233.00-8.79%
20223.29-13.17%
20213.79-40.56%
20206.3721.87%
20195.23-25.22%
20186.99-21.05%
20178.85-63.93%

Innovent Biologics, Inc. (1801.HK) Average Current Ratio

How has 1801.HK Current Ratio performed in the past?

The current Current Ratio of Innovent Biologics, Inc. (1801.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.88

5-year avg

3.76

10-year avg

7.16

Innovent Biologics, Inc. (1801.HK) Current Ratio vs. Peers

How is 1801.HK’s Current Ratio compared to its peers?

Innovent Biologics, Inc.’s Current Ratio is greater than BeiGene, Ltd. (1.96), less than WuXi Biologics (Cayman) Inc. (2.73), greater than Shanghai Junshi Biosciences Co., Ltd. (1.40), greater than WuXi AppTec Co., Ltd. (2.29), less than Akeso, Inc. (5.15),

Build a custom stock screener for Innovent Biologics, Inc. (1801.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Innovent Biologics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Innovent Biologics, Inc. (1801.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Innovent Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Innovent Biologics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Innovent Biologics, Inc. (1801.HK)?

What is the highest Current Ratio for Innovent Biologics, Inc. (1801.HK)?

What is the 3-year average Current Ratio for Innovent Biologics, Inc. (1801.HK)?

What is the 5-year average Current Ratio for Innovent Biologics, Inc. (1801.HK)?

How does the current Current Ratio for Innovent Biologics, Inc. (1801.HK) compare to its historical average?